SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-026386
Filing Date
2024-08-13
Accepted
2024-08-13 16:11:02
Documents
95
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20240630_10q.htm   iXBRL 10-Q 2323195
2 EXHIBIT 31.1 ex_709225.htm EX-31.1 7900
3 EXHIBIT 31.2 ex_709226.htm EX-31.2 8257
4 EXHIBIT 32.1 ex_709227.htm EX-32.1 3978
5 EXHIBIT 32.2 ex_709228.htm EX-32.2 3816
  Complete submission text file 0001437749-24-026386.txt   12416908

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nby-20240630.xsd EX-101.SCH 108257
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20240630_def.xml EX-101.DEF 701646
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20240630_lab.xml EX-101.LAB 547711
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20240630_pre.xml EX-101.PRE 745074
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20240630_cal.xml EX-101.CAL 42892
98 EXTRACTED XBRL INSTANCE DOCUMENT nby20240630_10q_htm.xml XML 2546213
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 241201538
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)